EntryPoint Capital LLC Acquires New Position in Tempus AI, Inc. $TEM

Key Points

• EntryPoint Capital LLC has acquired a new position in Tempus AI, purchasing 6,019 shares valued at approximately $290,000 during the first quarter, highlighting growing institutional interest in the company.
• Analysts have raised their price targets for Tempus AI's shares, with Guggenheim setting a target of $75.00 and a "buy" rating, reflecting positive market sentiment.
• In its latest earnings report, Tempus AI topped estimates with a revenue of $314.64 million, marking an impressive 89.5% year-over-year growth despite reporting a loss per share of ($0.22).

EntryPoint Capital LLC acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,019 shares of the company's stock, valued at approximately $290,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Pathway Capital Management LP purchased a new position in shares of Tempus AI during the first quarter valued at approximately $8,576,000. Wells Fargo & Company MN increased its position in Tempus AI by 13.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares during the last quarter. SeaCrest Wealth Management LLC acquired a new position in Tempus AI during the first quarter worth approximately $535,000. Sumitomo Mitsui Trust Group Inc. increased its position in Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in Tempus AI by 92.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company's stock worth $27,926,000 after purchasing an additional 278,311 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Analyst Ratings Changes

Several brokerages recently commented on TEM. Guggenheim upped their price target on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Bank of America upped their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Needham & Company LLC reaffirmed a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research report on Friday, August 8th. Morgan Stanley upped their price target on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Finally, Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus price target of $67.64.

Tempus AI Price Performance

Tempus AI stock opened at $80.52 on Friday. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $91.45. The firm has a fifty day moving average of $63.78 and a 200-day moving average of $59.21. The firm has a market capitalization of $13.99 billion, a P/E ratio of -67.66 and a beta of 4.98. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. During the same quarter in the prior year, the business earned ($6.86) earnings per share. The business's quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. As a group, analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling

In other news, COO Ryan Fukushima sold 17,460 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the sale, the chief operating officer owned 839,180 shares of the company's stock, valued at $62,644,787. This represents a 2.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erik Phelps sold 3,664 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the sale, the executive vice president directly owned 94,115 shares of the company's stock, valued at $7,025,684.75. The trade was a 3.75% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 776,451 shares of company stock valued at $53,022,688. 27.60% of the stock is owned by corporate insiders.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.